UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results

Frontiers in immunology, 2019-04, Vol.10, p.766-766

2019

Volltextzugriff (PDF)

A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma

Journal of translational medicine, 2019-11, Vol.17 (1), p.391-391, Article 391

2019

Volltextzugriff (PDF)

Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression

Cancer research (Chicago, Ill.), 2006-04, Vol.66 (8), p.4182-4190

2006

Volltextzugriff (PDF)

Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy

Oncoimmunology, 2017-09, Vol.6 (9), p.e1326442-e1326442

2017

Volltextzugriff (PDF)

Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes

Cancer research (Chicago, Ill.), 2009-07, Vol.69 (13), p.5312-5320

2009

Volltextzugriff (PDF)

Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine

Vaccines (Basel), 2020-01, Vol.8 (1), p.25

2020

Volltextzugriff (PDF)

Ionizing radiation selectively reduces skin regulatory T cells and alters immune function

PloS one, 2014-06, Vol.9 (6), p.e100800

2014

Volltextzugriff (PDF)

Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1

The FASEB journal, 2006-05, Vol.20 (7), p.1009-1011

2006

Volltextzugriff (PDF)

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy

Nature medicine, 2008-01, Vol.14 (1), p.28-36

2008

Volltextzugriff (PDF)

Immunotherapy for ovarian cancer: recent advances and perspectives

Current opinion in oncology, 2014-09, Vol.26 (5), p.492-500

2014

Volltextzugriff (PDF)

Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression

The Journal of clinical investigation, 2005-11, Vol.115 (11), p.3166-3176

2005

Volltextzugriff (PDF)

A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer

Journal of translational medicine, 2013-06, Vol.11 (1), p.149-149

2013

Volltextzugriff (PDF)

Potential approaches for more successful dendritic cell-based immunotherapy

Expert opinion on biological therapy, 2015-04, Vol.15 (4), p.569-582

2015

Volltextzugriff (PDF)

Abstract 1421: Interleukin-22, a protective factor for ovarian cancer during TNFa-induced apoptosis

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.1421-1421

2013

Volltextzugriff (PDF)

Abstract 5508: Geographic clustering of melanoma malignum with high thickness in the United States

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.5508-5508

2012

Volltextzugriff (PDF)

Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine

Vaccines (Basel), 2020-03, Vol.8 (1), p.1

2020

Volltextzugriff (PDF)

Effect of Solar Particle Event Radiation on Gastrointestinal Tract Bacterial Translocation and Immune Activation

Radiation research, 2011-04, Vol.175 (4), p.485-492

2011

Volltextzugriff (PDF)

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T^sub reg^ cells

Nature (London), 2011-07, Vol.475 (7355), p.226

2011

Volltextzugriff (PDF)

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and [T.sub.reg] cells

Nature (London), 2011-07, Vol.475 (7355), p.226

2011

Volltextzugriff (PDF)

Role of vascular leukocytes in ovarian cancer neovascularization

Advances in experimental medicine and biology, 2008, Vol.622, p.273

2008

Volltextzugriff (PDF)

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

Nature (London), 2011-07, Vol.475 (7355), p.226-230

2011

Volltextzugriff (PDF)

Activation of Notch1 signaling is required for -catenin-mediated human primary melanoma progression

The Journal of clinical investigation, 2005-11, Vol.115 (11), p.3166-3176

Balint, K.

2005

Volltextzugriff (PDF)

Notchi signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression

Cancer research (Chicago, Ill.), 2006, Vol.66 (8), p.4182-4190

2006

Volltextzugriff (PDF)

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells

Nature (London), 2011-07, Vol.475 (7355), p.226-230

2011

Volltextzugriff (PDF)

1 – 25 von 86

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(74)
Mit Volltextzugriff
(69)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma-A Proof of Antigen Discovery Feasibility in Three Patients

A Phase I/II trial comparing autologous dendritic cell vaccine pulsed either with personalized peptides (PEP-DC) or with tumor lysate (OC-DC) in patients with advanced high-grade ovarian serous carcinoma

Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression

Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy

Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes

Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine

Ionizing radiation selectively reduces skin regulatory T cells and alters immune function

Inhibition of endothelial cell proliferation by Notch1 signaling is mediated by repressing MAPK and PI3K/Akt pathways and requires MAML1

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy

Immunotherapy for ovarian cancer: recent advances and perspectives

Activation of Notch1 signaling is required for beta-catenin-mediated human primary melanoma progression

A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer

Potential approaches for more successful dendritic cell-based immunotherapy

Abstract 1421: Interleukin-22, a protective factor for ovarian cancer during TNFa-induced apoptosis

Abstract 5508: Geographic clustering of melanoma malignum with high thickness in the United States

Development and Optimization of a GMP-Compliant Manufacturing Process for a Personalized Tumor Lysate Dendritic Cell Vaccine

Effect of Solar Particle Event Radiation on Gastrointestinal Tract Bacterial Translocation and Immune Activation

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T^sub reg^ cells

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and [T.sub.reg] cells

Role of vascular leukocytes in ovarian cancer neovascularization

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and Treg cells

Activation of Notch1 signaling is required for -catenin-mediated human primary melanoma progression

Notchi signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells

Suchergebnisse filtern